Tradestie Institutional Equity Comparison Engine
IDRV vs IDNA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
IDNA Overall Edge
IDNA Captures Institutional Edge (1โ1 Pillars ยท 2โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to iShares Genomics Immunology and Healthcare ETF (IDNA) driven by superior Momentum & Technical while IDRV counters with relative strength in Options & Structure. Fundamentally, IDRV trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus IDNA at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, IDRV sits in UNCLASSIFIED (13th %ile IV; Dealer Gamma Walls on Pro) against IDNA sits in UNCLASSIFIED (20th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
IDRV N/M vs IDNA N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
IDNA
1Y -24.8% vs +52.0% ยท 52W Pos 0% vs 74%
Options & Structure Winner
IDRV
UNCLASSIFIED (13th %ile IV) vs UNCLASSIFIED (20th %ile IV)
IDRV
NYSE Arca
iShares Self-Driving EV and Tech ETF
Institutional Equity
$29.18
-2.34% 1D
Market Cap
N/A
1M Return
-7.1%
1Y Return
-24.79%
Forward P/E
N/M
Unified AI Score
36.7 / 100
SELL
Tech 36.0
Fund 51.0
Flow 50.0
Mom 64.0
IDNA
NYSE Arca
iShares Genomics Immunology and Healthcare ETF
Institutional Equity
$39.25
-2.12% 1D
Market Cap
N/A
1M Return
-3.18%
1Y Return
+51.96%
Forward P/E
N/M
Unified AI Score
41.7 / 100
SELL
Tech 28.0
Fund 33.0
Flow 50.0
Mom 21.8
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
IDRV -24.79%
IDNA +51.96%
Spread: +76.75 pp (IDNA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
IDRV TTM Op. Margin: N/A
IDNA TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IDRV vs IDNA. Trailing 12-month operating profitability (IDRV N/A vs IDNA N/A) and valuation multiples (IDRV N/M vs IDNA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | IDRV | IDNA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 0% ($29โ$46) | 74% ($25โ$44) | Stronger Trend | IDNA |
| Beta / 30D Volatility Risk Regime | 1.48ฮฒ ยท 28% Vol | 1.17ฮฒ ยท 44% Vol | Lower Realized Risk | IDRV |
| Unified Institutional Score Composite Signal | 36.7 / 100 (SELL) | 41.7 / 100 (SELL) | Higher Composite | IDNA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full IDRV vs IDNA Buy Guide
IDRV
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
13th %ile
IV Regime
Compressed (<25th %ile)
IDNA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
20th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither IDRV nor IDNA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.